Cherian Verghese

机构：University of Missouri

发表论文 54 篇 · 总被引 3573 次 · h-index 13

代表论文

Donanemab in Early Symptomatic Alzheimer Disease (2023 · JAMA · 被引 2751)
A Phase 3, 1-Year, Open-Label Trial of Valbenazine in Adults With Tardive Dyskinesia (2019 · Journal of Clinical Psychopharmacology · 被引 33)
Chimeric Antigen Receptor T-Cell Therapy: Reach to Solid Tumor Experience (2019 · Oncology · 被引 21)
Screening for Lung Cancer Has Limited Effectiveness Globally and Distracts From Much Needed Efforts to Reduce the Critical Worldwide Prevalence of Smoking and Related Morbidity and Mortality (2017 · Journal of Global Oncology · 被引 13)
Increased Incidence of Thrombotic Complications With Non-small Cell Lung Cancer Necessitates Consideration of Prophylactic Anticoagulation in Young Individuals (2021 · Cureus · 被引 7)
A long-term, open-label study of valbenazine for tardive dyskinesia (2020 · CNS Spectrums · 被引 7)